Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

3 Top Fidelity Mutual Funds To Buy

Published 12/03/2017, 08:13 PM
Updated 07/09/2023, 06:31 AM

Fidelity Investments is considered one of the leaders in the financial services industry with presence in eight countries of North America, Europe, Asia and Australia, and more than 400 research professionals. The company carries out operations in the United States through 10 regional offices and over 180 Investor Centers. The company provides investment advice, discount brokerage services, retirement services, wealth management services, securities execution, and clearance and life insurance products to its clients. It serves more than 24 million individual investors.

Fidelity had total assets of $6 trillion, with $2.3 trillion under management. The company manages over 200 mutual funds across a wide range of categories including both domestic as well as foreign funds, and equity and fixed income funds.

Below we share with you three top-ranked Fidelity mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of Fidelity funds, their Zacks Rank and past performance.

Fidelity Select Technology FSPTX seeks capital growth over the long run. FSPTX invests a large chunk of its assets in common stocks of companies primarily involved in production, development and sale of products used for technological advancement. The fund invests in both U.S. and non-U.S. companies. Factors including financial strength and economic condition are considered before investing in a company. Fidelity Select Technology Portfolio is non-diversified and has three-year annualized returns of 21.6%.

Charlie Chai is the fund manager of FSPTX since 2007.

Fidelity Select Medical Equipment and Systems Portfolio FSMEX invests a bulk of its assets in securities of companies that focus on research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies. The fund invests in securities of U.S. and non-U.S. companies. FSMEX seeks long-term capital appreciation. Fidelity Select Medical Equipment and Systems Portfolio has returned 15.7% in the last three-year period.

As of October 2017, FSMEX held 50 shares with 12.84% of its assets invested in Medtronic (NYSE:MDT) PLC.

Fidelity Growth Company FDGRX invests primarily in common stocks. FDGRX invests in companies that have above-average growth potential, while the advisor uses fundamental analysis of factors including each issuer's financial status and industry position, as well as market and economic conditions to select investments. FDGRX invests in both domestic and foreign issuers. Fidelity Growth Company has three-year annualized returns of 15.7%.

FDGRX has an expense ratio of 0.77% compared with the category average of 1.12%.

To view the Zacks Rank and past performance of all Fidelity mutual funds, investors can click here to see the complete list of funds.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>



Get Your Free (FSMEX): Fund Analysis Report

Get Your Free (FSPTX): Fund Analysis Report

Get Your Free (FDGRX): Fund Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.